Part, Chapter, Paragraph

 1 I, 2,2      |              endothelial cells of the source animal organ. Second, acute vascular
 2 I, 2,2      |                    engineering of the source animal. ~Chronic Xenograft Rejection.
 3 I, 2,3      |                   studied primarily in small animal models and in pig-to-nonhuman-primate
 4 I, 2,3      | pig-to-nonhuman-primate combinations. ~Small animal models. The principal model
 5 I, 2,3      |                      have emerged from small animal transplants are the following:
 6 I, 2,3      |              transplants as well.(31) ~Large animal models. The principal model
 7 I, 2,4      |                    There are no satisfactory animal models to test the pathogenicity
 8 II, 1       |                   that an organ or tissue of animal origin can have on the identity
 9 II, 1,8     |                breaching the barrier between animal species and the human species. ~
10 II, 1,8(56) |                               Cf. Singer P., Animal Liberation, 2nd edit., 1995,
11 II, 1,8(56) |                       Regan T., The case for Animal Rights, 1983, London, Routledge &
12 II, 1,8(56) |                Christian Medical Fellowship, Animal experimentation, 1997, (
13 II, 1,9     |                      conditions: unnecessary animal suffering must be prevented;
14 II, 1,9     |                balance of the species in the animal world must be avoided.(57) ~
15 II, 1,9     |                     utilization of different animal species (nonhuman primates
16 II, 1,9     |                   ritual basis, in using any animal as a source of organs or
17 II, 1,9(57) |                     human responsibility for animal life may be found in Schockenhoff
18 II, 1,9     |                      the acceptability of an animal organ, - once it has been
19 II, 2,12(64)|                     Promise of Transplanting Animal Organs into Humans, New
20 II, 2,12(64)|              Evaluation and Research, Source animal, product, preclinical, and
21 II, 2,14    |                 which are not harmful to the animal but which are possibly dangerous
22 II, 2,14    |             especially when it comes from an animal.(69) In the post-transplant
23 II, 2,15    |          implications. ~The term "transgenic animal" is used to indicate an
24 II, 2,15    |                       is used to indicate an animal whose genetic make-up has
25 II, 2,15    |                      done in respect for the animal and for biodiversity, and
26 II, 2,15    |                      identity of the mutated animal or its species, and reaffirming
27 II, 2,15    |                   behavioural aspects of the animal may be assessed, all the
28 II, 2,15    |                   anxiety experienced by the animal; ~2. The effects on the
29 II, 2,16    |                    attention.(70) ~Given the animal source of the organs which
30 II, 2,18    |             patenting genetically engineered animal organs intended for transplants.(72)
31 II, 2,18    |                   organs for transplant from animal to man, since this therapeutic
32 II, 2,18    |                  humans (as is the case with animal organs genetically engineered
33 II, 2,18    |                     view that the transgenic animal as such - and all the more
34 II, 3,19    |               pre-clinical experiments (from animal to animal) should continue
35 II, 3,19    |                  experiments (from animal to animal) should continue for as